Consensus or Controversy: Clinical Investigators Provide Perspectives on Targeted Treatment of Non-Small Cell Lung CancerConsensus or Controversy: Clinical Investigators Provide Perspectives on Targeted Treatment of Non-Small Cell Lung Cancer
Targeted therapy for patients with metastatic NSCLC and BRAF V600E mutations?
1:11 minutes. |